Core Scientific
CORZ
101 hedge funds and large institutions have $181M invested in Core Scientific in 2024 Q1 according to their latest regulatory filings, with 101 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1,448% more call options, than puts
Call options by funds: $51.4M | Put options by funds: $3.32M
28.72% more ownership
Funds ownership: 0% → 28.72% (+29%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Barings
Charlotte,
North Carolina
|
+$35.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.3M |
| 4 |
TSC
Two Seas Capital
Rye,
New York
|
+$13.3M |
| 5 |
KCM
Kensico Capital Management
Greenwich,
Connecticut
|
+$8.76M |
Top Sellers
CORZ Hedge Fund Activity: Q1 2024 in Review
101 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Core Scientific (CORZ) for Q1 2024, worth a combined $181M.
Buyers outnumbered sellers: 101 funds opened new CORZ positions and 0 closed out — a net gain of 101 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Barings, opening a new position worth an estimated $35.8M.
- 101 institutional investors held Core Scientific (CORZ) as of Q1 2024, up from 0 in Q4 2023.
- Funds reported $181M of Core Scientific stock for Q1 2024.
- 101 funds opened new Core Scientific positions in Q1 2024 and 0 closed out, a net change of +101 holders.
- The largest Core Scientific buyer in Q1 2024 was Barings, an estimated $35.8M added.
Based on aggregated 13F filings for Q1 2024.